Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.240
Open
1.170
VWAP
1.20
Vol
8.94K
Mkt Cap
11.09M
Low
1.170
Amount
10.77K
EV/EBITDA(TTM)
--
Total Shares
7.07M
EV
60.20M
EV/OCF(TTM)
--
P/S(TTM)
0.46
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2023Q4
6.74M
-40.74%
-0.400
-140.82%
Estimates Revision
Stock Price
Go Up
+41.84%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for DSS Inc (DSS.A) is 0.00, compared to its 5-year average forward P/E of -2.80. For a more detailed relative valuation and DCF analysis to assess DSS Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.80
Current PE
0.00
Overvalued PE
0.76
Undervalued PE
-6.35
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-5.74
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.82
Undervalued EV/EBITDA
-12.31
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.24
Current PS
1.22
Overvalued PS
2.55
Undervalued PS
-0.07
Financials
Annual
Quarterly
FY2025Q2
YoY :
+25.50%
5.29M
Total Revenue
FY2025Q2
YoY :
-30.60%
-3.43M
Operating Profit
FY2025Q2
YoY :
-47.38%
-2.61M
Net Income after Tax
FY2025Q2
YoY :
-63.64%
-0.24
EPS - Diluted
FY2025Q2
YoY :
-157.28%
1.98M
Free Cash Flow
FY2025Q2
YoY :
-88.34%
-4.05
Gross Profit Margin - %
FY2025Q2
YoY :
-58.07%
-49.33
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
3.1M
USD
7
0-12
Months
58.0
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
310.0
USD
Months
0-12
2
1,000K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
3.1M
USD
7
0-12
Months
58.0
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
310.0
USD
Months
0-12
2
1,000K
USD
Months
DSS News & Events
Events Timeline
2025-06-24 (ET)
2025-06-24
08:33:48
DSS' Impact BioMedical announces strategic merger with Dr. Ashley's
2025-05-22 (ET)
2025-05-22
08:32:59
DSS reports Q1 EPS (55c) vs. (58c) last year
2025-04-24 (ET)
2025-04-24
08:36:31
Sentinel Brokers Company receives FINRA approval to act as underwriter
Sign Up For More Events
Sign Up For More Events
News
2.0
08-27BenzingaMongoDB Shares Surge 31%; Check Out 20 Stocks Making Moves in Premarket Trading
9.5
05-22NewsfilterDSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
7.0
04-24NewsfilterSentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings
Sign Up For More News
People Also Watch
FAQ
What is DSS Inc (DSS) stock price today?
The current price of DSS is 1.22 USD — it has increased 0.83 % in the last trading day.
What is DSS Inc (DSS)'s business?
What is the price predicton of DSS Stock?
What is DSS Inc (DSS)'s revenue for the last quarter?
What is DSS Inc (DSS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for DSS Inc (DSS)'s fundamentals?
How many employees does DSS Inc (DSS). have?